Year-Long test aims to see if DMD pill can preserve muscle strength
NCT ID NCT06867107
Summary
This study follows up to 10 boys with Duchenne muscular dystrophy (DMD) who took an experimental oral drug called SAT-3247 in a previous trial. The goal is to check the long-term safety and see if taking the pill for a total of 12 months (including the first trial) can help control the disease by slowing muscle loss. Researchers will measure changes in arm muscle fat, strength, and function over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY (DMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Vincent Hospital
Melbourne, Victoria, Australia
Conditions
Explore the condition pages connected to this study.